Clinical Trial Update: ZD0473 and Doxorubicin in Treating Patients With Advanced Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating ZD0473 in combination with doxorubicin in adults with advanced solid tumors or lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Small Intestine Cancer

Drugs mentioned

• Doxorubicin (doxorubicin)
• ZD0473

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphoma, Small Intestine Cancer | Phase 1 | Status: COMPLETED